Literature DB >> 26911756

US cancer institute to overhaul tumour cell lines.

Heidi Ledford.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26911756     DOI: 10.1038/nature.2016.19364

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.

Authors:  Hui Gao; Joshua M Korn; Stéphane Ferretti; John E Monahan; Youzhen Wang; Mallika Singh; Chao Zhang; Christian Schnell; Guizhi Yang; Yun Zhang; O Alejandro Balbin; Stéphanie Barbe; Hongbo Cai; Fergal Casey; Susmita Chatterjee; Derek Y Chiang; Shannon Chuai; Shawn M Cogan; Scott D Collins; Ernesta Dammassa; Nicolas Ebel; Millicent Embry; John Green; Audrey Kauffmann; Colleen Kowal; Rebecca J Leary; Joseph Lehar; Ying Liang; Alice Loo; Edward Lorenzana; E Robert McDonald; Margaret E McLaughlin; Jason Merkin; Ronald Meyer; Tara L Naylor; Montesa Patawaran; Anupama Reddy; Claudia Röelli; David A Ruddy; Fernando Salangsang; Francesca Santacroce; Angad P Singh; Yan Tang; Walter Tinetto; Sonja Tobler; Roberto Velazquez; Kavitha Venkatesan; Fabian Von Arx; Hui Qin Wang; Zongyao Wang; Marion Wiesmann; Daniel Wyss; Fiona Xu; Hans Bitter; Peter Atadja; Emma Lees; Francesco Hofmann; En Li; Nicholas Keen; Robert Cozens; Michael Rugaard Jensen; Nancy K Pryer; Juliet A Williams; William R Sellers
Journal:  Nat Med       Date:  2015-10-19       Impact factor: 53.440

  1 in total
  37 in total

Review 1.  Heralding a new paradigm in 3D tumor modeling.

Authors:  Eliza L S Fong; Daniel A Harrington; Mary C Farach-Carson; Hanry Yu
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

2.  Patient-derived Xenografts from Colorectal Carcinoma: A Temporal and Hierarchical Study of Murine Stromal Cell Replacement.

Authors:  Celia Chao; Steve G Widen; Thomas G Wood; John R Zatarain; Paul Johnson; Aakash Gajjar; Guillermo Gomez; Suimin Qiu; Jill Thompson; Heidi Spratt; Mark R Hellmich
Journal:  Anticancer Res       Date:  2017-07       Impact factor: 2.480

Review 3.  The failure of rodent carcinogenesis as a model for Man.

Authors:  Colin Berry
Journal:  Toxicol Res (Camb)       Date:  2017-12-20       Impact factor: 3.524

Review 4.  A New View of Pathway-Driven Drug Resistance in Tumor Proliferation.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Trends Pharmacol Sci       Date:  2017-02-27       Impact factor: 14.819

Review 5.  Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials.

Authors:  C Norman Coleman; Geoff S Higgins; J Martin Brown; Michael Baumann; David G Kirsch; Henning Willers; Pataje G S Prasanna; Mark W Dewhirst; Eric J Bernhard; Mansoor M Ahmed
Journal:  Clin Cancer Res       Date:  2016-05-06       Impact factor: 12.531

6.  Expanding the concept of patient-derived xenografts cohorts in head and neck cancer: current and future perspectives.

Authors:  Zhi Yuan Zhang; Shu Yang Sun
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-12-01

Review 7.  Role of Biobanks for Cancer Research and Precision Medicine in Hepatocellular Carcinoma.

Authors:  Peyda Korhan; Sanem Tercan Avcı; Yeliz Yılmaz; Yasemin Öztemur Islakoğlu; Neşe Atabey
Journal:  J Gastrointest Cancer       Date:  2021-11-22

8.  Establishment and evaluation of four different types of patient-derived xenograft models.

Authors:  Xiaoqian Ji; Siyu Chen; Yanwu Guo; Wende Li; Xiaolong Qi; Han Yang; Sa Xiao; Guang Fang; Jinfang Hu; Chuangyu Wen; Huanliang Liu; Zhen Han; Guangxu Deng; Qingbin Yang; Xiangling Yang; Yuting Xu; Zhihong Peng; Fengping Li; Nvlue Cai; Guoxin Li; Ren Huang
Journal:  Cancer Cell Int       Date:  2017-12-20       Impact factor: 5.722

Review 9.  Addressing the challenges of applying precision oncology.

Authors:  Seung Ho Shin; Ann M Bode; Zigang Dong
Journal:  NPJ Precis Oncol       Date:  2017-09-04

10.  Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR.

Authors:  Sarah E Gill; Qing Zhang; Gary L Keeney; William A Cliby; S John Weroha
Journal:  Oncotarget       Date:  2017-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.